Mayo Clinic - Q2 2020 holdings

$105 Million is the total value of Mayo Clinic's 9 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .

 Value Shares↓ Weighting
BSM  Black Stone Minerals$37,122,000
+38.9%
5,711,1370.0%35.52%
-47.4%
UBX  Unity Biotechnology Inc$13,645,000
+49.7%
1,571,9810.0%13.06%
-43.4%
EVLO  Evelo Bioseciences Inc$2,376,000
+30.3%
484,9530.0%2.27%
-50.7%
MCRB  Seres Therapeutics Inc$857,000
+33.3%
180,0000.0%0.82%
-49.6%
CLPT  Clearpoint Neuro Inc (fka MRI INTERVENTIONS INC)$168,000
-0.6%
47,1480.0%0.16%
-62.3%
CGIX  CANCER GENETICS INC$1,0000.0%4440.0%0.00%
-66.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BLACK STONE MINERALS11Q3 202382.2%
Evelo Bioseciences Inc11Q3 20237.3%
BIOSIG TECH INC10Q2 20236.7%
Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC)10Q3 20233.5%
Zentalis Pharmaceuticals Inc9Q3 202322.6%
UNITY BIOTECHNOLOGY INC8Q4 202223.1%
EXACT SCIENCES CORP7Q2 20234.5%
Neuroon Medical Technologies5Q3 20231.3%
MSCI ACWI ETF4Q3 202389.6%
Sorrento Therapeutics4Q4 20226.1%

View Mayo Clinic's complete holdings history.

Latest significant ownerships (13-D/G)
Mayo Clinic Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VENTURE LENDING & LEASING IV INCMarch 16, 20056,0006.0%

View Mayo Clinic's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-13
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-09
13F-HR2023-05-05
13F-HR/A2023-02-09
13F-HR2023-01-26
13F-HR2021-08-12
13F-HR2021-05-13
13F-HR2021-02-11

View Mayo Clinic's complete filings history.

Compare quarters

Export Mayo Clinic's holdings